Naoya Teraoka, Isao Muraki, Hiroyasu Iso, Ryo Kawasaki, Manami Inoue, Shoichiro Tsugane, Norie Sawada, - For The Japan Public Health Center-Based Prospective Jphc Study Groupa
{"title":"The Association between Habitual Tub Bathing and Risk of Breast Cancer: The Japan Public Health Center-Based Prospective Study.","authors":"Naoya Teraoka, Isao Muraki, Hiroyasu Iso, Ryo Kawasaki, Manami Inoue, Shoichiro Tsugane, Norie Sawada, - For The Japan Public Health Center-Based Prospective Jphc Study Groupa","doi":"10.31557/APJCP.2025.26.5.1615","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Several studies reported that hot tub bathing, a unique Japanese culture, may benefit breast cancer risk factors. It is, however, uncertain whether moderate heat exposure through hot tub bathing could potentially reduce the risk of breast cancer. In this study, we aimed to investigate this association through a long-term prospective cohort study conducted in Japan.</p><p><strong>Methods: </strong>A total of 15,927 Japanese women aged 40-59 years with no history of breast cancer were followed up from 1990 to 2015. The frequency of tub bathing was categorized as 0-2 days/week, 3-4 days/week, and almost every day. The hazard ratios (HRs) and 95% confidence intervals (CIs) for the incident breast cancer were estimated using Cox proportional hazards models after adjusting for potential risk factors for breast cancer, including overweight.</p><p><strong>Results: </strong>During 367,950 person-years of the follow-up period, 370 breast cancer cases were identified. After adjusting for known confounders for breast cancer risk, the multivariable HR (95% CI) of incident breast cancer was 1.23 (0.93-1.62) for 3-4 days/week and 0.72 (0.40-1.31) for ≤2 days/week (trend p=0.90), compared to almost every day of tub bathing (p for trend = 0.90). No association was also seen for pre-menopausal or post-menopausal women and subjective lukewarm, warm, or hot bath temperatures.</p><p><strong>Conclusion: </strong>We found no reduced risk of breast cancer for women associated with frequent tub bathing. Further research is needed to obtain objective information on the frequency, duration, and water temperature of tub bathing.</p>","PeriodicalId":55451,"journal":{"name":"Asian Pacific Journal of Cancer Prevention","volume":"26 5","pages":"1615-1621"},"PeriodicalIF":0.0000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Asian Pacific Journal of Cancer Prevention","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31557/APJCP.2025.26.5.1615","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Several studies reported that hot tub bathing, a unique Japanese culture, may benefit breast cancer risk factors. It is, however, uncertain whether moderate heat exposure through hot tub bathing could potentially reduce the risk of breast cancer. In this study, we aimed to investigate this association through a long-term prospective cohort study conducted in Japan.
Methods: A total of 15,927 Japanese women aged 40-59 years with no history of breast cancer were followed up from 1990 to 2015. The frequency of tub bathing was categorized as 0-2 days/week, 3-4 days/week, and almost every day. The hazard ratios (HRs) and 95% confidence intervals (CIs) for the incident breast cancer were estimated using Cox proportional hazards models after adjusting for potential risk factors for breast cancer, including overweight.
Results: During 367,950 person-years of the follow-up period, 370 breast cancer cases were identified. After adjusting for known confounders for breast cancer risk, the multivariable HR (95% CI) of incident breast cancer was 1.23 (0.93-1.62) for 3-4 days/week and 0.72 (0.40-1.31) for ≤2 days/week (trend p=0.90), compared to almost every day of tub bathing (p for trend = 0.90). No association was also seen for pre-menopausal or post-menopausal women and subjective lukewarm, warm, or hot bath temperatures.
Conclusion: We found no reduced risk of breast cancer for women associated with frequent tub bathing. Further research is needed to obtain objective information on the frequency, duration, and water temperature of tub bathing.
期刊介绍:
Cancer is a very complex disease. While many aspects of carcinoge-nesis and oncogenesis are known, cancer control and prevention at the community level is however still in its infancy. Much more work needs to be done and many more steps need to be taken before effective strategies are developed. The multidisciplinary approaches and efforts to understand and control cancer in an effective and efficient manner, require highly trained scientists in all branches of the cancer sciences, from cellular and molecular aspects to patient care and palliation.
The Asia Pacific Organization for Cancer Prevention (APOCP) and its official publication, the Asia Pacific Journal of Cancer Prevention (APJCP), have served the community of cancer scientists very well and intends to continue to serve in this capacity to the best of its abilities. One of the objectives of the APOCP is to provide all relevant and current scientific information on the whole spectrum of cancer sciences. They aim to do this by providing a forum for communication and propagation of original and innovative research findings that have relevance to understanding the etiology, progression, treatment, and survival of patients, through their journal. The APJCP with its distinguished, diverse, and Asia-wide team of editors, reviewers, and readers, ensure the highest standards of research communication within the cancer sciences community across Asia as well as globally.
The APJCP publishes original research results under the following categories:
-Epidemiology, detection and screening.
-Cellular research and bio-markers.
-Identification of bio-targets and agents with novel mechanisms of action.
-Optimal clinical use of existing anti-cancer agents, including combination therapies.
-Radiation and surgery.
-Palliative care.
-Patient adherence, quality of life, satisfaction.
-Health economic evaluations.